Chengqian Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chengqian Huang has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Chong Liu
The First Affiliated Hospital of Guangxi Medical University, China
5 shared publications - Xinli Zhan
The First Affiliated Hospital of Guangxi Medical University, China
5 shared publications - Jiarui Chen
The First Affiliated Hospital of Guangxi Medical University, Nanning, China
4 shared publications - Chenxing Zhou
Department of Spine Surgery, The People’s Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China
3 shared publications - Jichong Zhu
The First Affiliated Hospital of Guangxi Medical University, Nanning, China
3 shared publications - Shaofeng Wu
The First Affiliated Hospital of Guangxi Medical University, Nanning, China
3 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Artificial Intelligence
- Vol. 9, 1909448
Prospective validation of multimodal risk stratification using clinical and quantitative imaging features for 12-month outcomes after minimally invasive surgery for lumbar disc herniation
Background: Lumbar disc herniation (LDH) is a common spinal disorder leading to chronic low back pain and radiating leg pain. Minimally invasive surgery is the preferred treatment, but postoperative recovery varies significantly, making accurate preoperative prognosis prediction a challenge. Methods: This study developed and prospectively validated a multimodal risk-stratification framework integrating structured clinical variables, conventional imaging parameters, CT/MRI radiomics, and high-dimensional image-derived features. A total of 773 patients were analyzed, including 665 patients in the retrospective development cohort and 108 patients in an independent prospective validation cohort. The retrospective cohort was divided into a training cohort ( n = 532) and an internal validation cohort ( n = 133). Feature selection, parameter optimization, and classification-threshold determination were performed exclusively within the training cohort, and the finalized framework was subsequently evaluated in the internal and prospective validation cohorts. Results: The integrated multimodal approach achieved an ROC-AUC of 0.937 (95% CI, 0.900–0.975) and a PR-AUC of 0.849 in the internal validation cohort, and an ROC-AUC of 0.976 (95% CI, 0.951–1.000) and a PR-AUC of 0.941 in the prospective validation cohort. Its discrimination was comparable to that achieved using structured clinical and conventional imaging information alone and was higher than that of isolated quantitative imaging approaches. At the prespecified training-derived classification threshold of 0.318, sensitivity, specificity, and balanced accuracy in the prospective cohort were 85.3%, 95.9%, and 90.6%, respectively. Calibration analysis demonstrated residual probability miscalibration despite strong discrimination, although training-derived logistic recalibration improved the Brier score. Conclusion: Multimodal integration of clinical and quantitative imaging information demonstrated strong discrimination for 12-month postoperative outcome stratification in both internal and prospective validation cohorts. However, the incremental discriminative value beyond structured clinical and conventional imaging information was limited, and residual miscalibration remained in the prospective cohort. Further multicenter validation, standardized quantitative imaging workflows, and calibration assessment are warranted before clinical translation.
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Artificial Intelligence
- Vol. 9, 1909448
Open AccessProspective validation of multimodal risk stratification using clinical and quantitative imaging features for 12-month outcomes after minimally invasive surgery for lumbar disc herniation
Background: Lumbar disc herniation (LDH) is a common spinal disorder leading to chronic low back pain and radiating leg pain. Minimally invasive surgery is the preferred treatment, but postoperative recovery varies significantly, making accurate preoperative prognosis prediction a challenge. Methods: This study developed and prospectively validated a multimodal risk-stratification framework integrating structured clinical variables, conventional imaging parameters, CT/MRI radiomics, and high-dimensional image-derived features. A total of 773 patients were analyzed, including 665 patients in the retrospective development cohort and 108 patients in an independent prospective validation cohort. The retrospective cohort was divided into a training cohort ( n = 532) and an internal validation cohort ( n = 133). Feature selection, parameter optimization, and classification-threshold determination were performed exclusively within the training cohort, and the finalized framework was subsequently evaluated in the internal and prospective validation cohorts. Results: The integrated multimodal approach achieved an ROC-AUC of 0.937 (95% CI, 0.900–0.975) and a PR-AUC of 0.849 in the internal validation cohort, and an ROC-AUC of 0.976 (95% CI, 0.951–1.000) and a PR-AUC of 0.941 in the prospective validation cohort. Its discrimination was comparable to that achieved using structured clinical and conventional imaging information alone and was higher than that of isolated quantitative imaging approaches. At the prespecified training-derived classification threshold of 0.318, sensitivity, specificity, and balanced accuracy in the prospective cohort were 85.3%, 95.9%, and 90.6%, respectively. Calibration analysis demonstrated residual probability miscalibration despite strong discrimination, although training-derived logistic recalibration improved the Brier score. Conclusion: Multimodal integration of clinical and quantitative imaging information demonstrated strong discrimination for 12-month postoperative outcome stratification in both internal and prospective validation cohorts. However, the incremental discriminative value beyond structured clinical and conventional imaging information was limited, and residual miscalibration remained in the prospective cohort. Further multicenter validation, standardized quantitative imaging workflows, and calibration assessment are warranted before clinical translation.
- Open Access
- 25 July 2026
- Published by Springer Nature in Complex & Intelligent Systems
- Vol. 12 (12)
Prior-attention multi-label model for ankylosing spondylitis diagnosis and assessment from pelvic X-rays: a multicenter study
This study aims to develop a multi-label classification model based on pelvic X-rays for the diagnosis and assessment of Ankylosing Spondylitis (AS), addressing the challenges of limited expert resources in underdeveloped regions. We propose a deep learning-based multi-label classification model incorporating a prior attention mechanism. This model utilizes predefined bounding boxes to accurately locate key areas, such as the bilateral sacroiliac joints and hip joint, allowing the model to focus on relevant regions during inference. The performance of the model was validated on a multi-center external test set. Experimental results demonstrate that the model achieves significant improvements in diagnostic performance and in the assessment performance of the sacroiliac joints and hip joints. The optimal model’s diagnostic performance achieved an accuracy of 0.875 on a multi-center external test set, surpassing doctors with less experience (0.798) and performing comparably to more experienced human experts (0.880). The accuracy for the assessment of left and right sacroiliac joints and left and right hip joints reached 0.964, 0.970, 0.827, and 0.863, respectively. The proposed multi-label classification model with a prior attention mechanism offers a promising, cost-effective tool for AS diagnosis and assessment, especially in resource-limited settings.
- 25 July 2026
- Published by Springer Nature in Complex & Intelligent Systems
- Vol. 12 (12)
Open AccessPrior-attention multi-label model for ankylosing spondylitis diagnosis and assessment from pelvic X-rays: a multicenter study
This study aims to develop a multi-label classification model based on pelvic X-rays for the diagnosis and assessment of Ankylosing Spondylitis (AS), addressing the challenges of limited expert resources in underdeveloped regions. We propose a deep learning-based multi-label classification model incorporating a prior attention mechanism. This model utilizes predefined bounding boxes to accurately locate key areas, such as the bilateral sacroiliac joints and hip joint, allowing the model to focus on relevant regions during inference. The performance of the model was validated on a multi-center external test set. Experimental results demonstrate that the model achieves significant improvements in diagnostic performance and in the assessment performance of the sacroiliac joints and hip joints. The optimal model’s diagnostic performance achieved an accuracy of 0.875 on a multi-center external test set, surpassing doctors with less experience (0.798) and performing comparably to more experienced human experts (0.880). The accuracy for the assessment of left and right sacroiliac joints and left and right hip joints reached 0.964, 0.970, 0.827, and 0.863, respectively. The proposed multi-label classification model with a prior attention mechanism offers a promising, cost-effective tool for AS diagnosis and assessment, especially in resource-limited settings.
- Open Access
- 11 February 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Multiomics combined drugs to explore the potential mechanism and treatment of ankylosing spondylitis
Ankylosing spondylitis (AS) is an immune-mediated disease with an unknown etiology, posing challenges in effective treatment. This study aims to investigat
- 11 February 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Open AccessMultiomics combined drugs to explore the potential mechanism and treatment of ankylosing spondylitis
Ankylosing spondylitis (AS) is an immune-mediated disease with an unknown etiology, posing challenges in effective treatment. This study aims to investigat
- 18 August 2025
- Published by Springer Nature in Clinical Rheumatology
- p. 1-14
Investigating the potential impact of gut microbiota and immune cells on ankylosing spondylitis based on single-cell sequencing and genetic variation analysis
Objectives Several observational studies suggest that gut microbiota (GM) may influence the onset and progression of ankylosing spondylitis (AS) through modulating host immune responses. However, the potential genetic associations between GM and AS susceptibility, as well as the immune-mediated mechanisms, remain to be elucidated. Method This study initially infers the causal associations among GM, immune cell traits (ICTs), and AS using univariate two-sample Mendelian randomization (MR), and then evaluates the mediating role of ICTs in the genetic association between GM and AS through mediation MR analysis. Meanwhile, single-cell RNA sequencing is conducted on vertebral bone marrow blood samples obtained from three AS patients and three controls to characterize the differentiation status and functional alterations of relevant immune cell subsets, thereby validating their contribution to the pathogenesis of AS. Result Mediation MR analysis revealed that “HLA-DR on CD14- CD16 + monocytes” acts as a protective factor for AS, attenuating the causal effect of Genus Sutterella/Sutterella Wadsworthensis on disease susceptibility. Single-cell analysis revealed distinct differences in cellular composition and transcriptional profiles between AS and the controls. Notably, monocyte subset analysis indicated a significant reduction in CD14- CD16 + monocytes in AS, concomitant with the relatively high expression of cellular activation markers. Conclusion The study indicates that CD14- CD16 + monocytes are potential protective factors for AS and exert a negative mediating effect on the causal associations between GM and AS. Boosting non-classical monocytes or modulating Sutterella abundance could help prevent or treat AS. Key Points • Novel approach integrating mediation MR and scRNA-seq offers distinct analytical strengths. • New insights into the gut-immune axis reveal its role in immune dysregulation in AS. • Mediation MR and single-cell analysis reveals CD14- CD16 + monocytes as protective factors in AS. • HLA-DR on CD14- CD16 + monocytes mitigate the genetic effect of Sutterella on AS susceptibility.
- 18 August 2025
- Published by Springer Nature in Clinical Rheumatology
- p. 1-14
Investigating the potential impact of gut microbiota and immune cells on ankylosing spondylitis based on single-cell sequencing and genetic variation analysis
Objectives Several observational studies suggest that gut microbiota (GM) may influence the onset and progression of ankylosing spondylitis (AS) through modulating host immune responses. However, the potential genetic associations between GM and AS susceptibility, as well as the immune-mediated mechanisms, remain to be elucidated. Method This study initially infers the causal associations among GM, immune cell traits (ICTs), and AS using univariate two-sample Mendelian randomization (MR), and then evaluates the mediating role of ICTs in the genetic association between GM and AS through mediation MR analysis. Meanwhile, single-cell RNA sequencing is conducted on vertebral bone marrow blood samples obtained from three AS patients and three controls to characterize the differentiation status and functional alterations of relevant immune cell subsets, thereby validating their contribution to the pathogenesis of AS. Result Mediation MR analysis revealed that “HLA-DR on CD14- CD16 + monocytes” acts as a protective factor for AS, attenuating the causal effect of Genus Sutterella/Sutterella Wadsworthensis on disease susceptibility. Single-cell analysis revealed distinct differences in cellular composition and transcriptional profiles between AS and the controls. Notably, monocyte subset analysis indicated a significant reduction in CD14- CD16 + monocytes in AS, concomitant with the relatively high expression of cellular activation markers. Conclusion The study indicates that CD14- CD16 + monocytes are potential protective factors for AS and exert a negative mediating effect on the causal associations between GM and AS. Boosting non-classical monocytes or modulating Sutterella abundance could help prevent or treat AS. Key Points • Novel approach integrating mediation MR and scRNA-seq offers distinct analytical strengths. • New insights into the gut-immune axis reveal its role in immune dysregulation in AS. • Mediation MR and single-cell analysis reveals CD14- CD16 + monocytes as protective factors in AS. • HLA-DR on CD14- CD16 + monocytes mitigate the genetic effect of Sutterella on AS susceptibility.
- 1 October 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 143 (Pt 1) , 113276
Integrating multiomics and Single-Cell communication analysis to uncover Ankylosing spondylitis mechanisms
- 1 October 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 143 (Pt 1) , 113276
Integrating multiomics and Single-Cell communication analysis to uncover Ankylosing spondylitis mechanisms